Health ❯Biotechnology

Drug Development

Clinical Trials Research Investments Protein Applications Vaccine Design Regulatory Affairs Antibodies Weight Loss Drugs Cancer Treatment Alzheimer's Drugs Press Releases

Biogen Announces Move to New Headquarters in Kendall Common

The Cambridge-based biotech will consolidate operations into a sustainable 580,000-square-foot facility set to open in 2028.

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns